MicroPort CardioFlow (2160 HK)

MicroPort CardioFlow Medtech Corporation is a medical device company specializing in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases. Its product portfolio includes transcatheter aortic valves, left atrial appendage closure systems, and cardiac rhythm management devices like pacemakers and implantable cardioverter-defibrillators. The company was founded in 2015 and is headquartered in Shanghai, China.